{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:41:20Z","timestamp":1792698080486,"version":"4.5.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.tem.2019.07.014","type":"journal-article","created":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T00:10:25Z","timestamp":1565482225000},"page":"756-766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Handling Parathormone Receptor Type 1 in Skeletal Diseases: Realities and Expectations of Abaloparatide"],"prefix":"10.1016","volume":"30","author":[{"given":"Juan A.","family":"Ardura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0659-1545","authenticated-orcid":false,"given":"Sergio","family":"Portal-N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arancha R.","family":"Gortazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2019.07.014_bb0005","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.bone.2005.11.024","article-title":"Osteoporosis: a still increasing prevalence","volume":"38","author":"Reginster","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.tem.2019.07.014_bb0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/ard.59.2.81","article-title":"The bone and joint decade 2000-2010","volume":"59","author":"Woolf","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.tem.2019.07.014_bb0015","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/jbmr.2269","article-title":"The recent prevalence of osteoporosis and low bone mass in the united states based on bone mineral density at the femoral neck or lumbar spine","volume":"29","author":"Wright","year":"2014","journal-title":"J.\u00a0Bone Min. Res."},{"key":"10.1016\/j.tem.2019.07.014_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11657-013-0137-0","article-title":"Osteoporosis in the European Union: a compendium of country-specific reports","volume":"8","author":"Svedbom","year":"2013","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.tem.2019.07.014_bb0025","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/jbmr.2393","article-title":"Risk of subsequent fractures and mortality in elderly women and men with fragility fractures with and without osteoporotic bone density: the Dubbo Osteoporosis Epidemiology Study","volume":"30","author":"Bliuc","year":"2015","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.tem.2019.07.014_bb0030","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","article-title":"An estimate of the worldwide prevalence and disability associated with osteoporotic fractures","volume":"17","author":"Johnell","year":"2006","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.tem.2019.07.014_bb0035","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s00198-010-1419-7","article-title":"Medical costs of osteoporosis in the elderly Medicare population","volume":"22","author":"Blume","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.tem.2019.07.014_bb0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bonr.2016.07.005","article-title":"Hospitalizations for osteoporosis-related fractures: economic costs and clinical outcomes","volume":"5","author":"Weycker","year":"2016","journal-title":"Bone Reports"},{"key":"10.1016\/j.tem.2019.07.014_bb0045","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00198-014-2655-z","article-title":"The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group","volume":"25","author":"Siris","year":"2014","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.tem.2019.07.014_bb0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: the first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.tem.2019.07.014_bb0055","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2019.07.014_bb0060","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/ijcp.12022","article-title":"Denosumab: mechanism of action and clinical outcomes","volume":"66","author":"Hanley","year":"2012","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.tem.2019.07.014_bb0065","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.tem.2019.07.014_bb0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jsbmb.2013.09.008","article-title":"Prevention and treatment of postmenopausal osteoporosis","volume":"142","author":"Gallagher","year":"2014","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tem.2019.07.014_bb0075","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/bonekey.2015.1","article-title":"Long-term safety of antiresorptive treatment: bone material, matrix and mineralization aspects","volume":"4","author":"Misof","year":"2015","journal-title":"Bonekey Rep."},{"key":"10.1016\/j.tem.2019.07.014_bb0080","first-page":"801","article-title":"Catabolic and anabolic actions of parathyroid hormone on the skeleton","volume":"34","author":"Silva","year":"2011","journal-title":"J.\u00a0Endocrinol. Investig."},{"key":"10.1016\/j.tem.2019.07.014_bb0085","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1302\/2058-5241.4.180018","article-title":"Molecular understanding of pharmacological treatment of osteoporosis","volume":"4","author":"Tanaka","year":"2019","journal-title":"EFORT Open Rev."},{"key":"10.1016\/j.tem.2019.07.014_bb0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/jbmr.3042","article-title":"Abaloparatide is an anabolic, but does it spare resorption?","volume":"32","author":"Martin","year":"2017","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.tem.2019.07.014_bb0095","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nrendo.2015.139","article-title":"PTH receptor-1 signalling\u00a0\u2013 mechanistic insights and therapeutic prospects","volume":"11","author":"Cheloha","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tem.2019.07.014_bb0100","doi-asserted-by":"crossref","first-page":"21836","DOI":"10.1074\/jbc.M909861199","article-title":"Minimization of parathyroid hormone: novel amino-terminal parathyroid hormone fragments with enhanced potency in activating the type-1 parathyroid hormone receptor","volume":"275","author":"Shimizu","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.tem.2019.07.014_bb0105","doi-asserted-by":"crossref","first-page":"19456","DOI":"10.1074\/jbc.M001596200","article-title":"Autoactivation of type-1 parathyroid hormone receptors containing a tethered ligand","volume":"275","author":"Shimizu","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.tem.2019.07.014_bb0110","doi-asserted-by":"crossref","first-page":"20200","DOI":"10.1074\/jbc.RA118.004751","article-title":"Parathyroid hormone(1-34) and its analogs differentially modulate osteoblastic Rankl expression via PKA\/SIK2\/SIK3 and PP1\/PP2A-CRTC3 signaling","volume":"293","author":"Ricarte","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.tem.2019.07.014_bb0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/en.2015-1726","article-title":"Binding selectivity of abaloparatide for PTH-type-1-receptor conformations and effects on downstream signaling","volume":"157","author":"Hattersley","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2019.07.014_bb0120","doi-asserted-by":"crossref","first-page":"16525","DOI":"10.1073\/pnas.0808750105","article-title":"Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformation","volume":"105","author":"Okazaki","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2019.07.014_bb0125","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nchembio.206","article-title":"Sustained cyclic AMP production by parathyroid hormone receptor endocytosis","volume":"5","author":"Ferrandon","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tem.2019.07.014_bb0130","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.cellsig.2009.02.012","article-title":"PTH and PTHrP signaling in osteoblasts","volume":"21","author":"Datta","year":"2009","journal-title":"Cell. Signal."},{"key":"10.1016\/j.tem.2019.07.014_bb0135","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00223-018-0422-4","article-title":"Abaloparatide exerts bone anabolic effects with less stimulation of bone resorption-related factors: a comparison with teriparatide","volume":"103","author":"Makino","year":"2018","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.tem.2019.07.014_bb0140","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1210\/en.2003-0273","article-title":"Parathyroid hormone-related peptide interacts with bone morphogenetic protein 2 to increase osteoblastogenesis and decrease adipogenesis in pluripotent C3H10T 1\/2 mesenchymal cells","volume":"144","author":"Chan","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2019.07.014_bb0145","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1172\/JCI91699","article-title":"Parathyroid hormone regulates fates of murine osteoblast precursors in\u00a0vivo","volume":"127","author":"Balani","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.tem.2019.07.014_bb0150","doi-asserted-by":"crossref","first-page":"19374","DOI":"10.1074\/jbc.M108913200","article-title":"Parathyroid hormone and parathyroid hormone-related protein exert both pro- and anti-apoptotic effects in mesenchymal cells","volume":"277","author":"Chen","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.tem.2019.07.014_bb0155","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1359\/JBMR.050106","article-title":"PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest","volume":"20","author":"Datta","year":"2005","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.tem.2019.07.014_bb0160","doi-asserted-by":"crossref","first-page":"20122","DOI":"10.1074\/jbc.M112.441360","article-title":"Parathyroid hormone (PTH)\/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH","volume":"288","author":"Saini","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.tem.2019.07.014_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13176","article-title":"SIKs control osteocyte responses to parathyroid hormone","volume":"7","author":"Wein","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2019.07.014_bb0170","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00003086-197709000-00036","article-title":"The cellular basis of bone turnover\u00a0and bone loss: a rebuttal of the osteocytic resorption\u00a0\u2013 bone flow theory","volume":"127","author":"Parfitt","year":"1977","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.tem.2019.07.014_bb0175","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","article-title":"The amazing osteocyte","volume":"26","author":"Bonewald","year":"2011","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.tem.2019.07.014_bb0180","first-page":"292","article-title":"Physiological and pathological osteocytic osteolysis","volume":"18","author":"Tsourdi","year":"2018","journal-title":"J.\u00a0Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.tem.2019.07.014_bb0185","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/jbmr.3011","article-title":"Control of bone anabolism in response to mechanical loading and PTH by distinct mechanisms downstream of the PTH receptor","volume":"32","author":"Delgado-Calle","year":"2017","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.tem.2019.07.014_bb0190","article-title":"Control of bone mass and remodeling by PTH receptor signaling in osteocytes","volume":"3","author":"O\u2019Brien","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.tem.2019.07.014_bb0195","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1074\/jbc.M115.679753","article-title":"Loss of Gs\u03b1 in the postnatal skeleton leads to low bone mass and a blunted response to anabolic parathyroid hormone therapy","volume":"291","author":"Sinha","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.tem.2019.07.014_bb0200","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/jbmr.2439","article-title":"Role of the parathyroid hormone type 1 receptor (PTH1R) as a mechanosensor in osteocyte survival","volume":"30","author":"Maycas","year":"2015","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.tem.2019.07.014_bb0205","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jbmr.3007","article-title":"PTHrP-derived peptides restore bone mass and strength in diabetic mice: additive effect of mechanical loading","volume":"32","author":"Maycas","year":"2017","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.tem.2019.07.014_bb0210","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1002\/art.23985","article-title":"Regulation of articular chondrocyte proliferation and differentiation by Indian hedgehog and parathyroid hormone-related protein in mice","volume":"58","author":"Chen","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.tem.2019.07.014_bb0215","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1002\/art.24843","article-title":"Parathyroid hormone 1-34 inhibits terminal differentiation of human articular chondrocytes and osteoarthritis progression in rats","volume":"60","author":"Chang","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.tem.2019.07.014_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/excr.2002.5580","article-title":"Four distinct chondrocyte populations in the fetal bovine growth plate: highest expression levels of PTH\/PTHrP receptor, Indian hedgehog, and MMP-13 in hypertrophic chondrocytes and their suppression by PTH (1-34) and PTHrP (1-40)","volume":"279","author":"Weisser","year":"2002","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.tem.2019.07.014_bb0225","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1359\/jbmr.2000.15.2.253","article-title":"Inhibition of chondrogenesis by parathyroid hormone in\u00a0vivo during repair of full-thickness defects of articular cartilage","volume":"15","author":"Kudo","year":"2000","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.tem.2019.07.014_bb0230","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.joca.2011.04.007","article-title":"Cartilaginous repair of full-thickness articular cartilage defects is induced by the intermittent activation of PTH\/PTHrP signaling","volume":"19","author":"Kudo","year":"2011","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.tem.2019.07.014_bb0235","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00223-016-0171-1","article-title":"Six weeks of daily abaloparatide treatment increased vertebral and femoral bone mineral density, microarchitecture and strength in ovariectomized osteopenic rats","volume":"99","author":"Bahar","year":"2016","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.tem.2019.07.014_bb0240","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00198-017-4323-6","article-title":"Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption","volume":"29","author":"Doyle","year":"2018","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.tem.2019.07.014_bb0245","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis","volume":"316","author":"Miller","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2019.07.014_bb0250","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/GME.0000000000001080","article-title":"Effects of abaloparatide on bone mineral density and risk of fracture in postmenopausal women aged 80 years or older with osteoporosis","volume":"25","author":"McClung","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.tem.2019.07.014_bb0255","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/jc.2014-3718","article-title":"Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis","volume":"100","author":"Leder","year":"2015","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2019.07.014_bb0260","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jbmr.2991","article-title":"Effects of abaloparatide-SC on fractures and bone mineral density in subgroups of postmenopausal women with osteoporosis and varying baseline risk factors","volume":"32","author":"Cosman","year":"2017","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.tem.2019.07.014_bb0265","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bone.2016.11.004","article-title":"Effects of abaloparatide-SC (BA058) on bone histology and histomorphometry: the ACTIVE phase 3 trial","volume":"97","author":"Moreira","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.tem.2019.07.014_bb0270","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/01926230601072301","article-title":"Defining a noncarcinogenic dose of recombinant human parathyroid hormone 1-84 in a 2-year study in Fischer 344 rats","volume":"34","author":"Jolette","year":"2006","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tem.2019.07.014_bb0275","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.yrtph.2017.04.001","article-title":"Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1\u201334)","volume":"86","author":"Jolette","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tem.2019.07.014_bb0280","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/jbmr.1800","article-title":"Safety of osteoanabolic therapy: a decade of experience","volume":"27","author":"Cipriani","year":"2012","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.tem.2019.07.014_bb0285","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","article-title":"Osteoporosis","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.tem.2019.07.014_bb0290","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0020-1383(16)47004-X","article-title":"Fracture healing in osteoporotic bone","volume":"47","author":"Cheung","year":"2016","journal-title":"Injury"},{"key":"10.1016\/j.tem.2019.07.014_bb0295","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1359\/jbmr.070724","article-title":"Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures","volume":"22","author":"Kakar","year":"2007","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.tem.2019.07.014_bb0300","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/jbm.a.35742","article-title":"Local delivery of parathyroid hormone-related protein-derived peptides coated onto a hydroxyapatite-based implant enhances bone regeneration in old and diabetic rats","volume":"104","author":"Ardura","year":"2016","journal-title":"J.\u00a0Biomed. Mater. Res. A"},{"key":"10.1016\/j.tem.2019.07.014_bb0305","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s004670000343","article-title":"Role of parathyroid hormone-related peptide and Indian hedgehog in skeletal development","volume":"14","author":"J\u00fcppner","year":"2000","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.tem.2019.07.014_bb0310","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.autrev.2018.06.002","article-title":"Osteoarthritis and its management \u2013 epidemiology, nutritional aspects and environmental factors","volume":"17","author":"Bortoluzzi","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.tem.2019.07.014_bb0315","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00774-018-0973-5","article-title":"miR-195 contributes to human osteoarthritis via targeting PTHrP","volume":"37","author":"Cao","year":"2018","journal-title":"J.\u00a0Bone Miner. Metab."},{"key":"10.1016\/j.tem.2019.07.014_bb0320","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.bbrc.2019.01.049","article-title":"Effect of the PTHrP(1-34) analog abaloparatide on inducing chondrogenesis involves inhibition of intracellular reactive oxygen species production","volume":"509","author":"Yang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tem.2019.07.014_bb0325","doi-asserted-by":"crossref","first-page":"101ra93","DOI":"10.1126\/scitranslmed.3002214","article-title":"Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis","volume":"3","author":"Sampson","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tem.2019.07.014_bb0330","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12967-018-1438-2","article-title":"Intermittent PTH administration improves alveolar bone formation in type 1 diabetic rats with periodontitis","volume":"16","author":"Kim","year":"2018","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.tem.2019.07.014_bb0335","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.mayocp.2016.10.009","article-title":"Eighteen months of treatment with subcutaneous abaloparatide followed by 6\u00a0months of treatment with alendronate in postmenopausal women with osteoporosis: results of the ACTIVExtend Trial","volume":"92","author":"Cosman","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.tem.2019.07.014_bb0340","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s40265-017-0780-7","article-title":"Abaloparatide: first global approval","volume":"77","author":"Shirley","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.tem.2019.07.014_bb0345","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.1658941","article-title":"A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide","volume":"254","author":"J\u00fcppner","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.tem.2019.07.014_bb0350","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1210\/endo.133.2.8393771","article-title":"Parathyroid hormone (PTH)\/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues","volume":"133","author":"Ure\u00f1a","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2019.07.014_bb0355","first-page":"18","article-title":"The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics","volume":"34","author":"Lombardi","year":"2011","journal-title":"J.\u00a0Endocrinol. Investig."},{"key":"10.1016\/j.tem.2019.07.014_bb0360","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3390\/cancers3010396","article-title":"Parathyroid hormone-related protein (PTHrP): a key regulator of life\/death decisions by tumor cells with potential clinical applications","volume":"3","author":"Luparello","year":"2011","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tem.2019.07.014_bb0365","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature01657","article-title":"Developmental regulation of the growth plate","volume":"423","author":"Kronenberg","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.tem.2019.07.014_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-010-0465-9","article-title":"Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm","volume":"68","author":"Vilardaga","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tem.2019.07.014_bb0375","doi-asserted-by":"crossref","first-page":"10856","DOI":"10.1074\/jbc.M513380200","article-title":"Distinct \u03b2-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1\/2 activation","volume":"281","author":"Gesty-Palmer","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.tem.2019.07.014_bb0380","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1074\/jbc.M115.697045","article-title":"Actin-sorting nexin 27 (SNX27)-retromer complex mediates rapid parathyroid hormone receptor recycling","volume":"291","author":"McGarvey","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.tem.2019.07.014_bb0385","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nature00816","article-title":"Na(+)\/H(+ ) exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling","volume":"417","author":"Mahon","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.tem.2019.07.014_bb0390","doi-asserted-by":"crossref","first-page":"14756","DOI":"10.1074\/jbc.M110.102970","article-title":"Parathyroid hormone receptor directly interacts with dishevelled to regulate beta-catenin signaling and osteoclastogenesis","volume":"285","author":"Romero","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.tem.2019.07.014_bb0395","doi-asserted-by":"crossref","first-page":"R203","DOI":"10.1530\/JME-16-0221","article-title":"Heterotrimeric G proteins in the control of parathyroid hormone actions","volume":"58","author":"Bastepe","year":"2017","journal-title":"J.\u00a0Mol. Endocrinol."},{"key":"10.1016\/j.tem.2019.07.014_bb0400","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1128\/MCB.01434-13","article-title":"The PTH-G s-protein kinase A cascade controls NAC localization to regulate bone mass","volume":"34","author":"Pellicelli","year":"2014","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tem.2019.07.014_bb0405","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.bone.2009.07.087","article-title":"Mechanical stress induces Interleukin-11 expression to stimulate osteoblast differentiation","volume":"45","author":"Kido","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.tem.2019.07.014_bb0410","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1210\/endo.132.5.8386606","article-title":"Cloned, stably expressed parathyroid hormone (PTH)\/PTH-related peptide receptors activate multiple messenger signals and biological responses in LLC-PK1 kidney cells","volume":"132","author":"Bringhurst","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2019.07.014_bb0415","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/en.2004-1283","article-title":"G alpha12\/G alpha13 subunits of heterotrimeric G proteins mediate parathyroid hormone activation of phospholipase D in UMR-106 osteoblastic cells","volume":"146","author":"Singh","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2019.07.014_bb0420","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1210\/en.2007-0343","article-title":"\u03b2-Arrestin-dependent parathyroid hormone-stimulated extracellular signal-regulated kinase activation and parathyroid hormone type 1 receptor internalization","volume":"148","author":"Sneddon","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2019.07.014_bb0425","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cellsig.2009.10.017","article-title":"Distinct roles for mitogen-activated protein kinase phosphatase-1 (MKP-1) and ERK-MAPK in PTH1R signaling during osteoblast proliferation and differentiation","volume":"22","author":"Datta","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.tem.2019.07.014_bb0430","doi-asserted-by":"crossref","first-page":"43312","DOI":"10.1074\/jbc.M112.422766","article-title":"Na+\/H+exchanger regulatory factor 1 (NHERF1) directly regulates osteogenesis","volume":"287","author":"Liu","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.tem.2019.07.014_bb0435","doi-asserted-by":"crossref","first-page":"E1363","DOI":"10.1152\/ajpendo.00034.2012","article-title":"Disruption of parathyroid hormone and parathyroid hormone-related peptide receptor phosphorylation prolongs ERK1\/2 MAPK activation and enhances c-fos expression","volume":"302","author":"Tawfeek","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276019301377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276019301377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:38:27Z","timestamp":1760906307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276019301377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":87,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1043276019301377"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2019.07.014","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Handling Parathormone Receptor Type 1 in Skeletal Diseases: Realities and Expectations of Abaloparatide","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2019.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}